CIM
DXCM icon

Calvert Investment Management’s DexCom DXCM Stock Holding History

Calvert Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-21,704
Closed -$324K – 183
2016
Q4 		$324K Sell
21,704
-224
-1% -$3.97K 0.01% 648
2016
Q3 		$481K Buy
21,928
+1,968
+10% +$43.8K 0.02% 541
2016
Q2 		$396K Buy
19,960
+1,820
+10% +$31K 0.02% 562
2016
Q1 		$308K Buy
18,140
+720
+4% +$12K 0.01% 591
2015
Q4 		$357K Buy
17,420
+3,980
+30% +$82.8K 0.02% 523
2015
Q3 		$288K Buy
13,440
+680
+5% +$15.2K 0.01% 488
2015
Q2 		$255K Buy
+12,760
New +$224K 0.01% 547

Other funds holding DXCM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Calvert Investment Management's DXCM Position: Q1 2017 in Review

Calvert Investment Management sold out of DexCom (DXCM) in Q1 2017, closing a stake of 21,704 shares — an estimated $324K sold.

Calvert Investment Management first reported a position in DXCM in Q2 2015 and held it in 7 quarters. The position peaked at $481K in Q3 2016. 321 funds tracked by Wall St. Rank hold DXCM as of Q1 2017.

  • Calvert Investment Management reported no remaining DexCom position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 21,704 DexCom shares in Q1 2017, an estimated $324K.
  • Calvert Investment Management first reported a position in DexCom in Q2 2015 and held it in 7 quarters.
  • Calvert Investment Management's DexCom position peaked at $481K in Q3 2016.
  • 321 funds tracked by Wall St. Rank held DexCom as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.